Concurrent Temozolomide and Dose-Escalated Intensity Modulated Radiation Therapy in Newly Diagnosed Glioblastoma

PURPOSE: To determine the maximum tolerated dose (MTD) of radiation (RT) with concurrent temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM), to estimate their progression free (PFS) and overall survival (OS), and to assess the role of (11)C methionine PET (MET-PET) imaging in pre...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Tsien, Christina I., Brown, Doris, Normolle, Daniel, Schipper, Matthew, Piert, Morand, Junck, Larry, Heth, Jason, Gomez-Hassan, Diana, Ten Haken, Randall K., Chenevert, Thomas, Cao, Yue, Lawrence, Theodore
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2011
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3266840/
https://ncbi.nlm.nih.gov/pubmed/22065084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-2073
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia